Skip to content
10-K

Annual Report

FULCRUM THERAPEUTICS, INC. FULC

0001193125-26-065197

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 66.6M sh
Shares Diluted FY 2025 · Dec 31, 2025 63.36K sh
Shares Diluted FY 2025 · Dec 31, 2024 61.98K sh
Capex FY 2025 · Dec 31, 2025 $314K
Capex FY 2025 · Dec 31, 2024 $278K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$60.07M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$2.22M
Cash And Equivalents FY 2025 · Dec 31, 2025 $197.53M
Cash And Equivalents FY 2025 · Dec 31, 2024 $58.21M
Stockholders Equity FY 2025 · Dec 31, 2025 $349M
Stockholders Equity FY 2025 · Dec 31, 2024 $243.03M
Stockholders Equity FY 2025 · Dec 31, 2023 $235.19M
Current Liabilities FY 2025 · Dec 31, 2025 $13.05M
Current Liabilities FY 2025 · Dec 31, 2024 $11.04M
Total Liabilities FY 2025 · Dec 31, 2025 $17.28M
Total Liabilities FY 2025 · Dec 31, 2024 $17.68M
Current Assets FY 2025 · Dec 31, 2025 $357.48M
Current Assets FY 2025 · Dec 31, 2024 $249.92M
Total Assets FY 2025 · Dec 31, 2025 $366.28M
Total Assets FY 2025 · Dec 31, 2024 $260.72M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.18
Eps Diluted FY 2025 · Dec 31, 2024 −$0.16
Eps Basic FY 2025 · Dec 31, 2025 −$1.18
Eps Basic FY 2025 · Dec 31, 2024 −$0.16
Sga Expense FY 2025 · Dec 31, 2025 $28.67M
Sga Expense FY 2025 · Dec 31, 2024 $36.45M
Rd Expense FY 2025 · Dec 31, 2025 $56.1M
Rd Expense FY 2025 · Dec 31, 2024 $63.39M
Net Income FY 2025 · Dec 31, 2025 −$74.88M
Net Income FY 2025 · Dec 31, 2024 −$9.73M
Operating Income FY 2025 · Dec 31, 2025 −$84.77M
Operating Income FY 2025 · Dec 31, 2024 −$21.9M